Patch Testing Results From the Massachusetts General Hospital Contact Dermatitis Clinic, 2007–2016

Dermatitis ◽  
2020 ◽  
Vol 31 (3) ◽  
pp. 202-208
Author(s):  
Idy Tam ◽  
Peter C. Schalock ◽  
Ernesto González ◽  
JiaDe Yu
Dermatitis ◽  
2009 ◽  
Vol 20 (2) ◽  
pp. 89-94 ◽  
Author(s):  
Lilla Landeck ◽  
Peter C. Schalock ◽  
Lynn A. Baden ◽  
Konrad Neumann ◽  
Ernesto Gonzalez

Dermatitis ◽  
2020 ◽  
Vol 31 (6) ◽  
pp. 359-366
Author(s):  
Idy Tam ◽  
JiaDe Yu ◽  
Lauren N. Ko ◽  
Peter C. Schalock

Author(s):  
Ronald S. Weinstein ◽  
N. Scott McNutt

The Type I simple cold block device was described by Bullivant and Ames in 1966 and represented the product of the first successful effort to simplify the equipment required to do sophisticated freeze-cleave techniques. Bullivant, Weinstein and Someda described the Type II device which is a modification of the Type I device and was developed as a collaborative effort at the Massachusetts General Hospital and the University of Auckland, New Zealand. The modifications reduced specimen contamination and provided controlled specimen warming for heat-etching of fracture faces. We have now tested the Mass. General Hospital version of the Type II device (called the “Type II-MGH device”) on a wide variety of biological specimens and have established temperature and pressure curves for routine heat-etching with the device.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Dan B. Ellis ◽  
Aalok Agarwala ◽  
Elena Cavallo ◽  
Pam Linov ◽  
Michael K. Hidrue ◽  
...  

Abstract Background The Massachusetts General Hospital is a large, quaternary care institution with 58 operating rooms, 164 anesthesiologists, 76 certified nurse anesthetists (CRNAs), an anesthesiology residency program that admits 25 residents annually, and 35 surgeons who perform laparoscopic, vaginal, and open hysterectomies. In March of 2018, our institution launched an Enhanced Recovery After Surgery (ERAS) pathway for patients undergoing hysterectomy. To implement the anesthesia bundle of this pathway, an intensive 14-month educational endeavor was created and put into effect. There were no subsequent additional educational interventions. Methods We retrospectively reviewed records of 2570 patients who underwent hysterectomy between October 2016 and March 2020 to determine adherence to the anesthesia bundle of the ERAS Hysterectomy pathway. RESULTS: Increased adherence to the four elements of the anesthesia bundle (p < 0.001) was achieved during the intervention period. Compliance with the pathway was sustained in the post-intervention period despite no additional actions. Conclusions Implementing the anesthesia bundle of an ERAS pathway in a large anesthesia group with diverse providers successfully occurred using implementation science-based approach of intense interventions, and these results were maintained after the intervention ceased.


Sign in / Sign up

Export Citation Format

Share Document